Pharmaceuticals, Biotechnology and Life Sciences
Sanofi announced Tuesday the launch of AVAXIM® Junior in the UK, an inactive hepatitis A vaccine indicated for use in children aged 12 months to 15 years inclusive to prevent...
Moderna said Monday that both of its bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger a superior antibody response compared to a booster dose of mRNA-1273, the Company's prototype vaccine,...
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA's approval of Botox Cosmetic.
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) 21 consortium have published a joint work plan until 2023....
Sanofi has launched its Diversity, Equity & Inclusion (DE&I) Board, the first-of-its-kind in the pharmaceutical industry to feature outside advisors....
— Data from the RLYB212 Phase 1b Proof-of-Concept Study to be Featured as an Oral Presentation at ISTH — —…
Proxy Cards Must be Received by 10:00 AM EDT on Tuesday, June 13th for Votes to Count Encourages Shareholders to…
DUBLIN–(BUSINESS WIRE)–The “US Pharma Packaging Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The US pharmaceutical…
– The COMMODORE 2 study demonstrated that subcutaneous crovalimab every four weeks was non-inferior to intravenous eculizumab every two weeks,…
DUBLIN–(BUSINESS WIRE)–The “Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023” report has been added to ResearchAndMarkets.com’s offering. This report…
CONSHOHOCKEN, Pa. & SAN FRANCISCO & FORT WORTH, Texas–(BUSINESS WIRE)–TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen…
DUBLIN–(BUSINESS WIRE)–The “APAC Vaccine Packaging Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The APAC vaccine…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres Therapeutics management, will participate…
DUBLIN–(BUSINESS WIRE)–The “The Global Exosome Market – Market Size, Forecast, Trials, and Trends, 2023” report has been added to ResearchAndMarkets.com’s…
Results from phase 1/2 EPCORE™ NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response…
